drugset / Trial / NCT00061256

The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients

NCT00061256

RandomizedParallel-groupDouble-blindTreatment

Summary

Alendronate is a drug that is used to treat osteoporosis. The purpose of this study is to examine whether alendronate in combination with calcium and vitamin D is safe and effective for treating bone loss in people with HIV.

Timeline

Start
Primary completion
Completion
2006-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule
Background Calcium carbonate Other / unclassified
Background Vitamin D Other / unclassified